| |
| |
|
| Insider
Information: |
Brumm Joshua T |
| Relationship: |
|
| City: |
Pleasanton |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
746,959 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$17,159,447 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
746,959 |
|
|
| Total
Value |
$17,159,447 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.5
|
| Percentage
Gain/Loss : |
0.0%
|
 267.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Zeltiq Aesthetics Inc |
ZLTQ |
VP of Corporate Develo... |
2012-02-17 |
7,692 |
2012-02-17 |
0 |
Premium* |
|
|
Aravive Inc |
ARAV |
COO and CFO |
2017-10-19 |
201,269 |
2014-04-15 |
0 |
Premium* |
|
|
Dyne Therapeutics, Inc. |
DYN |
|
2024-03-11 |
537,998 |
2020-09-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
64 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARAV |
Aravive Inc |
Chief Financial Officer |
• – – |
2016-10-11 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
68,835 |
0 |
- |
|
| ARAV |
Aravive Inc |
Chief Financial Officer |
• – – |
2014-12-26 |
4 |
A |
$0.00 |
$0 |
D/D |
10,445 |
36,635 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2022-07-06 |
4 |
D |
$8.24 |
$90,335 |
D/D |
(10,963) |
219,939 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2022-09-20 |
4 |
D |
$13.70 |
$162,153 |
D/D |
(11,836) |
204,623 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2023-09-18 |
4 |
AS |
$9.41 |
$113,221 |
D/D |
(12,032) |
233,679 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2022-10-07 |
4 |
S |
$13.37 |
$189,854 |
D/D |
(14,200) |
204,623 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2022-10-07 |
4 |
OE |
$1.03 |
$14,626 |
D/D |
14,200 |
218,823 |
0 |
- |
|
| ARAV |
Aravive Inc |
Chief Financial Officer |
• – – |
2014-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
25,000 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2022-10-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
15,500 |
189,123 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
CEO & President |
• • – |
2024-01-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
21,500 |
563,471 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2023-06-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
21,800 |
300,683 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2022-07-05 |
4 |
A |
$0.00 |
$0 |
D/D |
24,118 |
230,902 |
0 |
- |
|
| ARAV |
Aravive Inc |
Chief Financial Officer |
• – – |
2016-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
26,000 |
61,548 |
0 |
- |
|
| ARAV |
Aravive Inc |
COO and CFO |
• – – |
2017-02-24 |
4 |
OE |
$2.53 |
$75,900 |
D/D |
30,000 |
135,779 |
0 |
- |
|
| ARAV |
Aravive Inc |
COO and CFO |
• – – |
2017-02-24 |
4 |
AS |
$20.42 |
$628,063 |
D/D |
(30,000) |
105,779 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2023-06-08 |
4 |
OE |
$1.03 |
$30,991 |
D/D |
30,088 |
330,771 |
0 |
- |
|
| ARAV |
Aravive Inc |
COO and CFO |
• – – |
2017-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
43,900 |
108,724 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
CEO & President |
• • – |
2024-03-11 |
4 |
OE |
$5.54 |
$277,000 |
D/D |
50,000 |
604,385 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
CEO & President |
• – – |
2024-01-03 |
4 |
AS |
$18.34 |
$986,957 |
D/D |
(51,183) |
584,971 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
CEO & President |
• – – |
2024-01-03 |
4 |
OE |
$1.03 |
$52,718 |
D/D |
51,183 |
636,154 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2023-06-08 |
4 |
S |
$13.15 |
$806,690 |
D/D |
(61,000) |
269,771 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
CEO & President |
• • – |
2024-03-11 |
4 |
AS |
$25.42 |
$1,704,142 |
D/D |
(66,387) |
537,998 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2023-06-09 |
4 |
S |
$13.34 |
$1,021,604 |
D/D |
(76,582) |
269,771 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2023-06-09 |
4 |
OE |
$1.03 |
$78,879 |
D/D |
76,582 |
346,353 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
CEO & President |
• • – |
2024-03-01 |
4 |
OE |
$5.54 |
$523,419 |
D/D |
94,480 |
657,951 |
0 |
- |
|
64 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
